Anthony Petrone

Stock Analyst at Mizuho

(3.72)
# 686
Out of 5,182 analysts
218
Total ratings
49.11%
Success rate
7.64%
Average return

Stocks Rated by Anthony Petrone

MannKind
Apr 13, 2026
Maintains: Outperform
Price Target: $10$8
Current: $2.79
Upside: +186.74%
Medtronic
Apr 13, 2026
Maintains: Outperform
Price Target: $125$120
Current: $81.90
Upside: +46.52%
Lantheus Holdings
Apr 13, 2026
Maintains: Outperform
Price Target: $85$95
Current: $83.55
Upside: +13.70%
Intuitive Surgical
Apr 13, 2026
Maintains: Neutral
Price Target: $575$525
Current: $466.64
Upside: +12.51%
Inspire Medical Systems
Apr 13, 2026
Maintains: Outperform
Price Target: $85$70
Current: $55.11
Upside: +27.02%
Haemonetics
Apr 13, 2026
Maintains: Outperform
Price Target: $80$70
Current: $59.84
Upside: +16.98%
GE HealthCare Technologies
Apr 13, 2026
Maintains: Outperform
Price Target: $95$90
Current: $68.50
Upside: +31.39%
Edwards Lifesciences
Apr 13, 2026
Maintains: Outperform
Price Target: $100$95
Current: $82.28
Upside: +15.46%
Embecta
Apr 13, 2026
Maintains: Neutral
Price Target: $14$12
Current: $9.03
Upside: +32.89%
Boston Scientific
Apr 13, 2026
Maintains: Outperform
Price Target: $115$90
Current: $58.45
Upside: +53.98%
Maintains: Outperform
Price Target: $30$24
Current: $10.90
Upside: +120.18%
Initiates: Outperform
Price Target: $21
Current: $12.94
Upside: +62.29%
Maintains: Outperform
Price Target: $90$100
Current: $64.40
Upside: +55.28%
Maintains: Neutral
Price Target: $21$22
Current: $18.63
Upside: +18.09%
Maintains: Outperform
Price Target: $78$90
Current: $59.32
Upside: +51.72%
Maintains: Outperform
Price Target: $12$10
Current: $3.40
Upside: +194.12%
Maintains: Outperform
Price Target: $70$72
Current: $61.29
Upside: +17.47%
Maintains: Outperform
Price Target: $100$120
Current: $83.09
Upside: +44.42%
Maintains: Outperform
Price Target: $85$100
Current: $63.09
Upside: +58.50%
Initiates: Outperform
Price Target: $40
Current: $41.99
Upside: -4.74%
Maintains: Outperform
Price Target: $110$100
Current: $75.40
Upside: +32.63%
Maintains: Outperform
Price Target: $310$300
Current: $217.14
Upside: +38.16%
Maintains: Neutral
Price Target: $130$135
Current: $135.52
Upside: -0.38%
Maintains: Neutral
Price Target: $140$135
Current: $93.86
Upside: +43.83%
Maintains: Neutral
Price Target: $17$18
Current: $26.71
Upside: -32.60%
Maintains: Outperform
Price Target: $200$175
Current: $119.63
Upside: +46.28%
Initiates: Outperform
Price Target: $40
Current: $7.18
Upside: +457.10%
Maintains: Buy
Price Target: $54$58
Current: $62.09
Upside: -6.59%
Downgrades: Hold
Price Target: $63$67
Current: $112.40
Upside: -40.39%
Maintains: Buy
Price Target: $200$175
Current: $82.80
Upside: +111.35%
Maintains: Hold
Price Target: $30$25
Current: $12.07
Upside: +107.13%